Rate My Professor Joseph Turner

Turner's academic interests focus on reproductive options and autonomy, particularly progesterone-after-mifepristone interventions, fertility awareness methods (FAMs/FABMs), infertility, natural family planning, bioethics, and structure-activity as well as structure-pharmacokinetic relationships. He teaches clinical examination skills, general practice, research methodologies for medical professionals, women’s and reproductive health, and pregnancy care. Notable publications include "Congenital and fetal effects after mifepristone exposure and continuation of pregnancy: a systematic review" (Clinical Pharmacology & Therapeutics, 2024), "Progesterone after mifepristone: A pilot prospective single arm clinical trial for women who have changed their mind after commencing medical abortion" (Journal of Obstetrics and Gynaecology Research, 2024), "Challenging misleading information about ‘abortion reversal’" (BMJ Sexual & Reproductive Health, 2024), and "Relationship Between Steroid Hormone Profile and Premenstrual Syndrome in Women Consulting for Infertility or Recurrent Miscarriage" (Reproductive Sciences, 2024). Earlier contributions feature pharmacokinetic modeling, such as "Bioavailability prediction based on molecular structure for a diverse series of drugs" (Pharmaceutical Research, 2004), and authored books including "Quantitative structure-pharmacokinetic relationships: Artificial neural network modeling" (2008).